MedTrace Logo

Osia CPT Code Study

NCT04320407 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-11-25

Study results available
· View outcomes & findings →

Summary

To evaluate the clinical efficacy of the Osia 2 system in patients with conductive or mixed conductive hearing loss in a US cohort.

Conditions

  • Conductive Hearing Loss
  • Mixed Hearing Loss

Interventions

DEVICE

Osia 2 System

The external Sound Processor, Osia 2 Active Osseointegrated Implant System for Bone Conduction, captures and digitizes the sound which is transferred to the internal implant where it is converted to an electrical signal.

Sponsors & Collaborators

  • Cochlear

    lead INDUSTRY

Principal Investigators

  • Mark Syms, MD · Arizona Hearing Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-30
Primary Completion
2021-10-05
Completion
2021-12-28
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04320407 on ClinicalTrials.gov